CRON INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Cronos Group Inc. Investors to Contact Firm's Attorneys, Firm Investigating Cronos' Admitted Improper Accounting

Hagens Berman urges Cronos Group Inc. (NASDAQ:CRON) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims

Visit: www.hbsslaw.com/investor-fraud/CRON

Contact An Attorney Now: CRON@hbsslaw.com

844-916-0895

Cronos Group Inc. (CRON) Investigation:

In past quarters Cronos has maintained it reports its financial results in accordance with Generally Accepted Accounting Principles, including for its goodwill valuations and making timely impairment charges.

But the company's public disclosures came into serious question on Nov. 9, 2021, when Cronos announced (1) it would restate its financial statements for the three and six months ended June 30, 2021, and (2) it should have recorded "an impairment charge of not less than $220 million on goodwill and indefinite-lived intangible assets in its U.S. reporting unit." The company also announced it would not timely file its quarterly report for the period ended Sept. 30, 2021.

This news sent the price of Cronos shares sharply lower on Nov. 9, 2021.

"We're focused on investors' losses and whether Cronos knowingly overstated its assets to appear healthier than it actually was," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Cronos and have significant losses, or have knowledge that may assist the firm's investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Cronos should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email CRON@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP



View source version on accesswire.com:
https://www.accesswire.com/672684/CRON-INVESTOR-ALERT-Hagens-Berman-National-Trial-Attorneys-Encourages-Cronos-Group-Inc-CRON-Investors-to-Contact-Firms-Attorneys-Firm-Investigating-Cronos-Admitted-Improper-Accounting

News Provided by ACCESSWIRE IA via QuoteMedia

The Conversation (0)
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...

Latest Press Releases

Related News